# Vancomycin Versus Daptomycin for the Treatment of Methicillin-resistant Staphylococcus Aureus Bacteremia Due to Isolates With High Vancomycin Minimum Inhibitory Concentrations (MICs)

> **NCT01287832** · PHASE4 · TERMINATED · sponsor: **St. John Health System, Michigan** · enrollment: 11 (actual)

## Conditions studied

- Bacteremia

## Interventions

- **DRUG:** Vancomycin
- **DRUG:** Daptomycin

## Key facts

- **NCT ID:** NCT01287832
- **Lead sponsor:** St. John Health System, Michigan
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2011-06
- **Primary completion:** 2012-01
- **Final completion:** 2012-01
- **Target enrollment:** 11 (ACTUAL)
- **Why stopped:** Low patient enrollment
- **Last updated:** 2014-02-10

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01287832

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01287832, "Vancomycin Versus Daptomycin for the Treatment of Methicillin-resistant Staphylococcus Aureus Bacteremia Due to Isolates With High Vancomycin Minimum Inhibitory Concentrations (MICs)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01287832. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*